Nociceptin binding sites in frog (Rana esculenta) brain membranes
- PMID: 10403810
- DOI: 10.1006/bbrc.1999.0907
Nociceptin binding sites in frog (Rana esculenta) brain membranes
Abstract
The recently discovered natural heptadecapeptide nociceptin (orphanin FQ) shares some homology with the opioid peptides but it binds to a distinct receptor type, termed nociceptin receptor. This study demonstrates the presence of specific nociceptin recognition sites in brain membrane fractions of an amphibian, Rana esculenta. Para-iodo-Phe(1)-nociceptin-amide was radiolabelled by catalytic dehalotritiation, resulting in p[(3)H]Phe(1)-nociceptin-amide of 25 Ci/mmol specific radioactivity. Specific binding of [(3)H]nociceptin-amide to frog brain membranes was found to be saturable and of high affinity with equilibrium K(d) values in the low nanomolar range. A single set of binding sites with about 180 fmol/mg protein maximal binding capacity was obtained in saturation and competition experiments. [(3)H]Nociceptin-amide binding could easily be inhibited by synthetic nociceptin compounds but not by opioid ligands. Both sodium ions and 5'-guanylylimidodiphosphate decreased the binding of the radioligand by transferring the receptor to a lower affinity state. Nociceptin dose-dependently stimulated the binding of the nonhydrolysable, radiolabeled GTP-analogue guanosine-5'-O-(3-thio)triphosphate ([(35)S]GTPgammaS) to G-proteins in frog brain membranes. Addition of 1 microM naloxone caused no significant change in the curves, indicating that nociceptin-mediated activation of G-proteins occurred through nonopioid mechanism.
Copyright 1999 Academic Press.
Similar articles
-
Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.J Pharmacol Exp Ther. 1998 Aug;286(2):896-902. J Pharmacol Exp Ther. 1998. PMID: 9694948
-
In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.Neuroreport. 2001 Jun 13;12(8):1757-61. doi: 10.1097/00001756-200106130-00048. Neuroreport. 2001. PMID: 11409754
-
Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.Br J Pharmacol. 1999 Nov;128(6):1300-6. doi: 10.1038/sj.bjp.0702907. Br J Pharmacol. 1999. PMID: 10578145 Free PMC article.
-
Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.Vitam Horm. 2015;97:1-55. doi: 10.1016/bs.vh.2014.10.001. Epub 2015 Jan 14. Vitam Horm. 2015. PMID: 25677767 Review.
-
Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system.Peptides. 2000 Jul;21(7):1023-9. doi: 10.1016/s0196-9781(00)00233-3. Peptides. 2000. PMID: 10998536 Review.
Cited by
-
In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord.Br J Pharmacol. 2003 Aug;139(8):1462-8. doi: 10.1038/sj.bjp.0705371. Br J Pharmacol. 2003. PMID: 12922933 Free PMC article.
-
The evolution of vertebrate opioid receptors.Front Biosci (Landmark Ed). 2009 Jan 1;14(4):1247-69. doi: 10.2741/3306. Front Biosci (Landmark Ed). 2009. PMID: 19273128 Free PMC article. Review.
-
Nociceptin produces antinociception after spinal administration in amphibians.Pharmacol Biochem Behav. 2009 Jan;91(3):436-40. doi: 10.1016/j.pbb.2008.08.022. Epub 2008 Sep 5. Pharmacol Biochem Behav. 2009. PMID: 18804120 Free PMC article.
-
A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.Eur J Pharmacol. 2008 Dec 3;599(1-3):36-43. doi: 10.1016/j.ejphar.2008.09.043. Epub 2008 Oct 9. Eur J Pharmacol. 2008. PMID: 18930720 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources